ID   SOX11_RAT               Reviewed;         395 AA.
AC   P0C1G9; O35178; O89036; Q04889;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   27-JUN-2006, sequence version 1.
DT   24-JUL-2024, entry version 125.
DE   RecName: Full=Transcription factor SOX-11;
GN   Name=Sox11;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9632656; DOI=10.1074/jbc.273.26.16050;
RA   Kuhlbrodt K., Herbarth B., Sock E., Enderich J., Hermans-Borgmeyer I.,
RA   Wegner M.;
RT   "Cooperative function of POU proteins and SOX proteins in glial cells.";
RL   J. Biol. Chem. 273:16050-16057(1998).
CC   -!- FUNCTION: Transcription factor that acts as a transcriptional activator
CC       (By similarity). Binds cooperatively with POU3F2/BRN2 or POU3F1/OCT6 to
CC       gene promoters, which enhances transcriptional activation (By
CC       similarity). Acts as a transcriptional activator of TEAD2 by binding to
CC       its gene promoter and first intron (By similarity). Plays a redundant
CC       role with SOX4 and SOX12 in cell survival of developing tissues such as
CC       the neural tube, branchial arches and somites, thereby contributing to
CC       organogenesis (By similarity). {ECO:0000250|UniProtKB:Q7M6Y2}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q7M6Y2,
CC       ECO:0000255|PROSITE-ProRule:PRU00267}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ004858; CAA06166.1; -; mRNA.
DR   RefSeq; NP_445801.1; NM_053349.1.
DR   AlphaFoldDB; P0C1G9; -.
DR   SMR; P0C1G9; -.
DR   STRING; 10116.ENSRNOP00000040127; -.
DR   PhosphoSitePlus; P0C1G9; -.
DR   PaxDb; 10116-ENSRNOP00000040127; -.
DR   Ensembl; ENSRNOT00000045963.5; ENSRNOP00000040127.3; ENSRNOG00000030034.5.
DR   Ensembl; ENSRNOT00055009669; ENSRNOP00055007474; ENSRNOG00055005963.
DR   Ensembl; ENSRNOT00060016064; ENSRNOP00060012573; ENSRNOG00060009512.
DR   Ensembl; ENSRNOT00065018027; ENSRNOP00065013751; ENSRNOG00065011137.
DR   GeneID; 84046; -.
DR   KEGG; rno:84046; -.
DR   AGR; RGD:69351; -.
DR   CTD; 6664; -.
DR   RGD; 69351; Sox11.
DR   eggNOG; KOG0527; Eukaryota.
DR   GeneTree; ENSGT00940000161652; -.
DR   HOGENOM; CLU_043342_0_0_1; -.
DR   InParanoid; P0C1G9; -.
DR   OMA; AAHHGDY; -.
DR   OrthoDB; 2902801at2759; -.
DR   PhylomeDB; P0C1G9; -.
DR   TreeFam; TF351735; -.
DR   PRO; PR:P0C1G9; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000030034; Expressed in brain and 6 other cell types or tissues.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:GO_Central.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:GO_Central.
DR   GO; GO:0007420; P:brain development; IBA:GO_Central.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; IBA:GO_Central.
DR   GO; GO:0061386; P:closure of optic fissure; ISS:UniProtKB.
DR   GO; GO:0061303; P:cornea development in camera-type eye; ISS:UniProtKB.
DR   GO; GO:0048557; P:embryonic digestive tract morphogenesis; ISS:UniProtKB.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; ISS:UniProtKB.
DR   GO; GO:0061029; P:eyelid development in camera-type eye; ISS:UniProtKB.
DR   GO; GO:0021782; P:glial cell development; ISO:RGD.
DR   GO; GO:0014009; P:glial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0060022; P:hard palate development; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IEP:RGD.
DR   GO; GO:0002089; P:lens morphogenesis in camera-type eye; ISS:UniProtKB.
DR   GO; GO:0060425; P:lung morphogenesis; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0050672; P:negative regulation of lymphocyte proliferation; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IMP:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; ISS:UniProtKB.
DR   GO; GO:0060563; P:neuroepithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.
DR   GO; GO:0003357; P:noradrenergic neuron differentiation; IMP:UniProtKB.
DR   GO; GO:0014003; P:oligodendrocyte development; IEP:RGD.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISS:UniProtKB.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0035332; P:positive regulation of hippo signaling; ISS:UniProtKB.
DR   GO; GO:0046887; P:positive regulation of hormone secretion; ISS:UniProtKB.
DR   GO; GO:2001111; P:positive regulation of lens epithelial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0050769; P:positive regulation of neurogenesis; ISS:UniProtKB.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045778; P:positive regulation of ossification; ISS:UniProtKB.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:2000648; P:positive regulation of stem cell proliferation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; ISO:RGD.
DR   GO; GO:0060023; P:soft palate development; ISS:UniProtKB.
DR   GO; GO:0021510; P:spinal cord development; ISS:UniProtKB.
DR   GO; GO:0048485; P:sympathetic nervous system development; ISS:UniProtKB.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISS:UniProtKB.
DR   CDD; cd22037; HMG-box_SoxC_SOX11; 1.
DR   Gene3D; 1.10.30.10; High mobility group box domain; 1.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR017386; SOX-12/11/4.
DR   InterPro; IPR050140; SRY-related_HMG-box_TFs.
DR   PANTHER; PTHR10270; SOX TRANSCRIPTION FACTOR; 1.
DR   PANTHER; PTHR10270:SF113; TRANSCRIPTION FACTOR SOX-11; 1.
DR   Pfam; PF00505; HMG_box; 1.
DR   PIRSF; PIRSF038098; SOX-12/11/4a; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; HMG-box; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
PE   2: Evidence at transcript level;
KW   Activator; Developmental protein; Differentiation; DNA-binding;
KW   Neurogenesis; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..395
FT                   /note="Transcription factor SOX-11"
FT                   /id="PRO_0000244267"
FT   DNA_BIND        49..117
FT                   /note="HMG box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00267"
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          114..258
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          276..312
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          363..395
FT                   /note="Required for transcriptional activation activity and
FT                   synergistic coactivation of transcriptional activity with
FT                   POU3F2"
FT                   /evidence="ECO:0000250|UniProtKB:Q7M6Y2"
FT   COMPBIAS        114..128
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        201..218
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        291..309
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   395 AA;  42599 MW;  0AE6CBF6CE991D58 CRC64;
     MVQQAESSEA ESNLPRDALD TEEGEFMACS PVALDESDPD WCKTASGHIK RPMNAFMVWS
     KIERRKIMEQ SPDMHNAEIS KRLGKRWKML KDSEKIPFIR EAERLRLKHM ADYPDYKYRP
     RKKPKTDPAA KPSAGQSPDK SAAGAKAAKG PGKKCAKLKA PAGKAGAGKA AQPGDCGAGK
     AAKCVFLDDD DEEDDEDDEL QLRPKPDADD DDDEPAHSHL LPPPAQQQPP QLLRRYSVAK
     VPASPTLSSA AESPEGASLY DEVRAGGRLY YSFKNITKQQ PPPAPPALSP ASSRCVSTSS
     SSGSSSGSGA EDADDLMFDL SLNFSQGAHS ACEQPLGAGA AGNLSLSLVD KDLDSFSEGS
     LGSHFEFPDY CTPELSEMIA GDWLEANFSD LVFTY
//
